Latest filing published 13 Mar 2008 for SCOLR Pharma, Inc., €33k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Randall L. W. Caudill is a declared insider at 2 companies; the most frequent names are SCOLR Pharma, Inc. and Vaxgen Inc. In total, 3 filings cover trades dated from 16 November 2007 to 11 March 2008.
Market trades split into 1 purchase (€4,442) and 1 sale (€26k). The net balance comes to €21k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. Since January 2008: no purchases and 1 sale on the market.
Most recently, on 13 March 2008, the filings show a share grant worth €33k in SCOLR Pharma, Inc. The last purchase on record was published on 19 November 2007, which is 6,914 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations